Skip to main content
. 2017 May 9;8(42):71782–71796. doi: 10.18632/oncotarget.17710

Figure 4. Binding site assay of compound WX-132-18B on tubulin.

Figure 4

(A) WX-132-18B competitively inhibited the binding of colchicine to tubulin. The inhibition rate is expressed as the percentage (%) of decreased fluorescence of the colchicine-tubulin complex. (B) The impact of compounds on the binding of BODIPY FL-vinblastine-tubulin complex. Values are mean±SD, n=3. (C) Limited proteolysis assay. Tubulin was digested with trypsin following preincubation with vehicle (0.1% dimethyl sulfoxide), 10 μM of colchicine, vincristine, and WX-132-18B. Tubulin treated with WX-132-18B showed patterns of proteolysis similar to those of colchicine.